Research Article
The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID-19 Patients
Table 2
Multivariate associations with in-hospital mortality among patients hospitalized with COVID-19.
| Factor | Odds ratio (95% CI) | value |
| Age | 1.07 (1.03–1.1) | 0.001 | Sex | 0.31 (0.12–0.78) | 0.013 | Race | 0.80 (0.50–1.28) | 0.358 | Obesity (BMI ≥30) | 1.54 (0.69–3.48) | 0.291 | GFR (<60) | 2.65 (1.03–6.79) | 0.042 | DM | 0.44 (0.18–1.34) | 0.090 | HTN | 1.14 (0.41–3.14) | 0.793 | CAD | 0.62 (0.16–2.40) | 0.488 | COPD | 1.07 (0.24–4.71) | 0.924 | AF | 0.82 (0.14–4.72) | 0.827 | CHF | 1.01 (0.61–5.44) | 0.281 | ICU admission | 42.52 (14.85–121.74) | 0.001 | Albumin, mean (SD) | 0.35 (0.139–0.89) | 0.028 | CRP | 1.05 (0.99–1.11) | 0.072 | Ferritin | 1.00 (0.99–1.00) | 0.090 | D-dimer | 0.99 (0.99–1.00) | 0.300 | Lymphocyte | 1.53 (0.63–3.64) | 0.340 |
|
|
BMI: body mass index, GFR: glomerular filtration rate, AKI: acute kidney injury, DM: diabetes mellitus, HTN: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, AF: atrial fibrillation, CHF: congestive heart failure, CRP: C-reactive protein.
|